Jump to main content
Jump to site search

Issue 7, 2017
Previous Article Next Article

Antibiotics from Gram-negative bacteria: a comprehensive overview and selected biosynthetic highlights

Author affiliations

Abstract

Covering: up to 2017

The overwhelming majority of antibiotics in clinical use originate from Gram-positive Actinobacteria. In recent years, however, Gram-negative bacteria have become increasingly recognised as a rich yet underexplored source of novel antimicrobials, with the potential to combat the looming health threat posed by antibiotic resistance. In this article, we have compiled a comprehensive list of natural products with antimicrobial activity from Gram-negative bacteria, including information on their biosynthetic origin(s) and molecular target(s), where known. We also provide a detailed discussion of several unusual pathways for antibiotic biosynthesis in Gram-negative bacteria, serving to highlight the exceptional biocatalytic repertoire of this group of microorganisms.

Graphical abstract: Antibiotics from Gram-negative bacteria: a comprehensive overview and selected biosynthetic highlights

Back to tab navigation

Publication details

The article was received on 31 Jan 2017 and first published on 26 Jun 2017


Article type: Review Article
DOI: 10.1039/C7NP00010C
Citation: Nat. Prod. Rep., 2017,34, 712-783
  •   Request permissions

    Antibiotics from Gram-negative bacteria: a comprehensive overview and selected biosynthetic highlights

    J. Masschelein, M. Jenner and G. L. Challis, Nat. Prod. Rep., 2017, 34, 712
    DOI: 10.1039/C7NP00010C

Search articles by author

Spotlight

Advertisements